SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Objective To delineate the epileptology, a key part of the SYNGAP1 phenotypic spectrum, in a large patient cohort. Methods Patients were recruited via investigators9 practices or social media. We included patients with (likely) pathogenic SYNGAP1 variants or chromosome 6p21.32 microdeletions incorporating SYNGAP1. We analyzed patients9 phenotypes using a standardized epilepsy questionnaire, medical records, EEG, MRI, and seizure videos. Results We included 57 patients (53% male, median age 8 years) with SYNGAP1 mutations (n = 53) or microdeletions (n = 4). Of the 57 patients, 56 had epilepsy: generalized in 55, with focal seizures in 7 and infantile spasms in 1. Median seizure onset age was 2 years. A novel type of drop attack was identified comprising eyelid myoclonia evolving to a myoclonic-atonic (n = 5) or atonic (n = 8) seizure. Seizure types included eyelid myoclonia with absences (65%), myoclonic seizures (34%), atypical (20%) and typical (18%) absences, and atonic seizures (14%), triggered by eating in 25%. Developmental delay preceded seizure onset in 54 of 56 (96%) patients for whom early developmental history was available. Developmental plateauing or regression occurred with seizures in 56 in the context of a developmental and epileptic encephalopathy (DEE). Fifty-five of 57 patients had intellectual disability, which was moderate to severe in 50. Other common features included behavioral problems (73%); high pain threshold (72%); eating problems, including oral aversion (68%); hypotonia (67%); sleeping problems (62%); autism spectrum disorder (54%); and ataxia or gait abnormalities (51%). Conclusions SYNGAP1 mutations cause a generalized DEE with a distinctive syndrome combining epilepsy with eyelid myoclonia with absences and myoclonic-atonic seizures, as well as a predilection to seizures triggered by eating.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic presentation of SYNGAP1 mutations and microdeletions (A) in patients of our cohort or (B) previously published in the literature Chromosome 6p21.32 microdeletions including SYNGAP1, are presented as gray bars with << and >> indicating that their breakpoints were outside the region presented here. Truncating (◆) and splice-site (→) mutations are presented above the gene, and missense and in-frame (•) mutations are shown underneath the gene. Bold variants concern recurrent variants that were identified in our cohort but also previously published in the literature. Colors of the lines represent the epilepsy syndrome phenotype: moderate to severe developmental and epileptic encephalopathy (red), moderate to severe developmental encephalopathy with epilepsy (orange), moderate to severe developmental encephalopathy with no epilepsy (blue), mild developmental and epileptic encephalopathy (light green), mild developmental encephalopathy with no epilepsy (dark green), and unknown/unclassified epilepsy (gray). Chromosomal coordinates were based on National Center for Biotechnology Information Build 37 [hg19] and SYNGAP1 mutations, protein domains, and exons on the longest isoform 1 (NM_006772.2).](https://figures.cochat.ai/paper-figures/4a1a5df8aed94e85828827f53344021a/i-syngap1-i-encephalopathy-a-distinctive-generalized-developmental-and-epileptic-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The severity of epilepsy in patients with DEEs should not reduce the focus on comorbidities as cognitive, psychiatric (such as ASD, anxiety, mood and behavioural disorders, psychosis), motor and medical disorders occur frequently 110,152,153,156,215 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [110]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with DEEs are at high risk of the typical medical complications associated with severe neurodevelopmental impairment, including aspiration pneumonia, feeding problems, constipation, sleep disorders and orthopaedic deformities 110,152,215 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [110]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pathogenic variants in SYNGAP1 cause a generalised DEE with myoclonic-atonic seizures, absence with eyelid myoclonia, eating-induced reflex seizures and photosensitivity [108][109][110] .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [110]
The cited source says what the claim attributes to it.
In the citing paper
“psychiatric features such as ASD 110 , behavioural problems 152 , mood disorders, psychosis 153 ;”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · cited 1×
“ck70sj0).(29) We included 57 (86%) patients with (likely) pathogenic SYNGAP1 variants (n = 53) or chromosome 6p21.”
BackgroundAnalysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587 · cited 1×
“Three patients who had variants reported in gnomAD or ExAC and for whom inheritance of their SYNGAP1 variant was unavailable had phenotypes that were consistent with our large cohort.(38) Two had generalized DEE and 1 had mild ID with EM.”
ResultUniProt: a hub for protein information
The UniProt Consortium (2015) · Nucleic Acids Research · doi:10.1093/nar/gku989 · Cited by 5,106
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Self-citationFisher, R. S., Cross, J. H., French, J. A., Higurashi, N., Hirsch, E., Jansen, F. E., Lagae, L., Moshé, S. L., Peltola, J., Roulet Perez, E., et al. (2017) · Epilepsia · doi:10.1111/epi.13670 · Cited by 3,483
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
Prevalence and architecture of de novo mutations in developmental disorders
Study, D. D. D. (2017) · Nature · doi:10.1038/nature21062 · Cited by 1,480
Krawczak, M., Reiss, J., & Cooper, D. (1992) · Human Genetics · doi:10.1007/bf00210743 · Cited by 1,324 · cited 1×
“Splice-site mutations were considered separately because their effects on the protein are variable.(35)”
Background
Research works printed but not linked: 1
- Fisher RS , Cross JH , French JA , et al . Operational classification of seizure types by the International League Against Epilepsy [online serial]. Epilepsia 2017:1–9. Available at: ilae.org. Accessed January 17, 2018.
Cited by
Specchio, N., Wirrell, E. C., Scheffer, I. E., Nabbout, R., Riney, K., Samia, P., Guerreiro, M., Gwer, S., Zuberi, S. M., Wilmshurst, J. M., et al. (2022) · Epilepsia · doi:10.1111/epi.17241 · Cited by 998
Self-citationTwenty Years of SynGAP Research: From Synapses to Cognition
Gamache, T. R., Araki, Y., & Huganir, R. L. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0420-19.2020 · Cited by 161
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationVisually sensitive seizures: An updated review by the Epilepsy Foundation
Fisher, R. S., Acharya, J. N., Baumer, F. M., French, J. A., Parisi, P., Solodar, J., Szaflarski, J. P., Thio, L. L., Tolchin, B. D., Wilkins, A. J., et al. (2022) · Epilepsia · doi:10.1111/epi.17175 · Cited by 158
SynGAP isoforms differentially regulate synaptic plasticity and dendritic development
Araki, Y., Hong, I., Gamache, T. R., Ju, S., Collado-Torres, L., Shin, J. H., & Huganir, R. L. (2020) · eLife · doi:10.7554/elife.56273 · Cited by 102
Metadata
- Authors
- Vlaskamp, D. R. M., Shaw, B. J., Burgess, R., Mei, D., Montomoli, M., Xie, H., Myers, C. T., Bennett, M. F., XiangWei, W., Williams, D., Maas, S. M., Brooks, A. S., Mancini, G. M. S., van de Laar, I. M. B. H., van Hagen, J. M., Ware, T. L., Webster, R. I., Malone, S., Berkovic, S. F., Kalnins, R. M., Sicca, F., Korenke, G. C., van Ravenswaaij-Arts, C. M. A., Hildebrand, M. S., Mefford, H. C., Jiang, Y., Guerrini, R., & Scheffer, I. E.
- Affiliations
- University Medical Center Groningen (NL)
- From the Epilepsy Research Centre (D.R.M.V., B.J.S., R.B., M.F.B., S.F.B., M.S.H., I.E.S.), Department of Medicine, University of Melbourne, Austin Health, Australia; Departments of Genetics (D.R.M.V., C.M.A.v.R.-A.) and Neurology (D.R.M.V.), University Medical Center Groningen, University of Groningen, the Netherlands; Pediatric Neurology Unit and Laboratories (D.M., M.M.) and Pediatric Neurology (R.G.), Neurogenetics and Neurobiology Unit and Laboratories, A. Meyer Children's Hospital, University...
- Corresponding author
- Scheffer, Ingrid E.
- ORCID
- Vlaskamp, Danique R.M.
- Burgess, Rosemary
- Mei, Davide
- Montomoli, Martino
- Xie, Han
- Myers, Candace T.
- Bennett, Mark F.
- XiangWei, Wenshu
- Maas, Saskia M.
- Brooks, Alice S.
- Mancini, Grazia M.S.
- van de Laar, Ingrid M.B.H.
- Ware, Tyson L.
- Webster, Richard I.
- Malone, Stephen
- Berkovic, Samuel F.
- Kalnins, Renate M.
- Sicca, Federico
- Korenke, G. Christoph
- van Ravenswaaij-Arts, Conny M.A.
- Hildebrand, Michael S.
- Mefford, Heather C.
- Jiang, Yuwu
- Guerrini, Renzo
- Scheffer, Ingrid E.
- Venue
- Neurology
- Published
- 2019-01-08
- Volume
- 92
- Issue
- 2
- Pages
- e96-e107
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC6340340
- OpenAlex
- W2904696555
- Cited by
- 206
- References
- 50
- Citations by year
- 2026: 20 · 2025: 32 · 2024: 39 · 2023: 27 · 2022: 21 · 2021: 30 · 2020: 27 · 2019: 7
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Neurology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- U.S. Department of Defense
- March of Dimes Foundation
- Citizens United for Research in Epilepsy
- Fondazione Pisa
- Zogenix
- GW Pharmaceuticals
- Australian Government
- European Commission (602531)
- National Natural Science Foundation of China (2016‐2020, 81501123)
- Ministero della Salute
- Eisai
- Fondazione Pierfranco e Luisa Mariani
- Regione Toscana
- National Institutes of Health
- Medical Research Council
- National Health and Medical Research Council (1091593, 1104831)
- Health Research Council of New Zealand
- National Institute of Neurological Disorders and Stroke (R01NS069605)
- UCB Pharma
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- SYNGAP1, developmental and epileptic encephalopathy, epileptology, eyelid myoclonia with absences, myoclonic-atonic seizures, atonic seizures, intellectual disability, autism spectrum disorder, developmental delay, behavioral problems
- MeSH terms
- Adolescent, Adult, Anticonvulsants, Brain, Brain Diseases, Child, Developmental Disabilities, Child, Preschool, Electroencephalography, Female, Humans, Infant, Male, Mutation, Spasms, Infantile, Cohort Studies, ras GTPase-Activating Proteins, Young Adult, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy. https://app.cochat.ai/papers/10.1212/wnl.0000000000006729
- The paper
- Vlaskamp, D. R. M., Shaw, B. J., Burgess, R., Mei, D., Montomoli, M., Xie, H., Myers, C. T., Bennett, M. F., XiangWei, W., Williams, D., Maas, S. M., Brooks, A. S., Mancini, G. M. S., van de Laar, I. M. B. H., van Hagen, J. M., Ware, T. L., Webster, R. I., Malone, S., Berkovic, S. F., . . . Scheffer, I. E. (2019). SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy. Neurology. https://doi.org/10.1212/wnl.0000000000006729
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.